IntegraGen Licenses Biomarkers to Develop Dx for Liver Cancer

IntegraGen plans to validate tools developed under the agreement within the next two years under clinical conditions.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.